We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
PNTOA | Panther Metals Ltd | 0.003 | 0.002 | 200.00% | 500,000 | 1 |
AQXOC | Alice Queen Limited | 0.002 | 0.001 | 100.00% | 1,000,000 | 1 |
TMSOA | Tennant Minerals Ltd | 0.002 | 0.001 | 100.00% | 60,713 | 1 |
JTL | Jayex Technology Limited | 0.002 | 0.001 | 100.00% | 1,332,885 | 8 |
AVW | Avira Resources Limited | 0.002 | 0.001 | 100.00% | 1,000,000 | 8 |
VPR | Volt Power Group Limited | 0.0015 | 0.0005 | 50.00% | 9,282,602 | 9 |
NKLO | NickelX Limited | 0.003 | 0.001 | 50.00% | 3,333 | 1 |
1MC | Morella Corporation Ltd | 0.003 | 0.001 | 50.00% | 21,021,761 | 68 |
MRQ | MRG Metals Ltd | 0.0015 | 0.0005 | 50.00% | 514,275 | 3 |
JAV | Javelin Minerals Ltd | 0.0015 | 0.0005 | 50.00% | 550,894 | 4 |
MTL | Mantle Minerals Limited | 0.003 | 0.001 | 50.00% | 650,412 | 6 |
SINGAPORE, May 13, 2024 /PRNewswire/ -- Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN) (the "Company"), a global leader in solar innovation and channels, today announced it will postpone the release of its Fourth Quarter, Fiscal Year 2023 and First Quarter 2024 Financial Results, previously scheduled for May 15, 2024 U.S. ET / May 16, Singapore Time, to May 23, 2024. The additional time is necessary to complete the Company's preparation of its annual and quarterly reports and to provide the market with a comprehensive business update.
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, is pleased to announce the appointment of Greg DiPasquale as Senior Vice President, Head of Commercial, effective immediately. DiPasquale will oversee sales, marketing, and sales operations for Harrow’s rapidly growing portfolio of branded ophthalmic products. This new role reflects Harrow’s commitment to enhancing its leadership structure to support the Company’s continued growth. John Saharek, Harrow’s Chief Commercial Officer and Chief Executive Officer of ImprimisRx, will continue to oversee Harrow’s commercial business, focusing on the day-to-day management of Harrow’s market‑leading compounded division.
CARMEL, Ind., May 14, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that the Company is a subcontractor for LUKE, a prime contractor on a 10-year $43 billion Defense Health Agency (DHA) Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract, for the Medical Q-Coded Support and Services – Next Generation Program (MQS2-NG ), to provide medical staffing services at DHA facilities across the country.
Company to Host Conference Call at 5:00 pm ET Monday May 13, 2024 PORTLAND, Oregon, May 13, 2024 /PRNewswire/ -- Eastside Distilling, Inc. (NASDAQ: EAST) ("Eastside" or the "Company"), a consumer-focused beverage company that builds craft inspired experiential brands and high-quality artisanal products around premium spirits, digital can printing, co-packing and mobile filling, reported first quarter financial results for the period ended March 31, 2024.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 61,940.73 | -963.04 | -1.53% | 1.21T | 3,802,008,223 |
ETH | Ethereum | 2,911.82 | -37.43 | -1.27% | 348.45B | 1,634,321,606 |
USDT | Tether USD | 0.9994 | -0.00041 | -0.04% | 97.78B | 212,202,444 |
BNB | Binance Coin | 570.17 | -21.25 | -3.59% | 89.76B | 188,132,893 |
SOL | Solana | 144.22 | -3.15 | -2.14% | 63.31B | 898,083,846 |
STETH | stETH | 2,908.30 | -29.66 | -1.01% | 28.42B | 2,883,822 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 699,384,980 |
XRP | Ripple | 0.5066 | 0.0014 | 0.28% | 27.55B | 238,063,512 |
TONCOIN | Wrapped TON Coin | 6.68 | -0.362912 | -5.15% | 23.08B | 258,813,852 |
DOGE | Dogecoin | 0.14915 | 0.00063 | 0.42% | 21.35B | 803,403,566 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions